New submitter Beeftopia writes with perhaps distressing news about cancer research. From the article: "During a decade as head of global cancer research at Amgen, C. Glenn Begley identified 53 'landmark' publications — papers in top journals, from reputable labs — for his team to reproduce. Begley sought to double-check the findings before trying to build on them for drug development. Result: 47 of the 53 could not be replicated. He described his findings in a commentary piece published on Wednesday in the journal Nature (paywalled) . ... But they and others fear the phenomenon is the product of a skewed system of incentives that has academics cutting corners to further their careers."
As is the fashion at Nature
, you can only read the actual article if you are a subscriber or want to fork over $32. Anyone with access care to provide more insight?
Update: 04/06 14:00 GMT
by U L
pointed us toward informative commentary in Pipeline